June 30, 2011
Reporting from Washington —A panel of advisors to the Food and Drug Administration voted 6 to 0 to halt the use of the cancer drug Avastin for the treatment of breast cancer, saying studies have failed to show Avastin is effective for that purpose.
via latimes.com
No comments:
Post a Comment